z-logo
open-access-imgOpen Access
Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
Author(s) -
Sara Sadeghi,
Azadeh Goodarzi
Publication year - 2022
Publication title -
dermatology practical and conceptual
Language(s) - English
Resource type - Journals
ISSN - 2160-9381
DOI - 10.5826/dpc.1204a178
Subject(s) - tofacitinib , ruxolitinib , medicine , janus kinase , janus kinase inhibitor , psoriasis , vitiligo , immunology , abatacept , rheumatoid arthritis , alopecia areata , dermatology , rheumatology , rituximab , cytokine , bone marrow , lymphoma , myelofibrosis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here